Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies for the biotechnology and pharmaceutical industries. By leveraging innovative automated solutions, comprehensive biorepository services, and advanced storage technologies, the company enables clients to accelerate drug discovery while adhering to stringent regulatory requirements. With a strong emphasis on cutting-edge technology and strategic partnerships, Azenta is well-positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to advancing scientific research through sophisticated products further solidifies its competitive advantage in biobanking and sample management.
| Revenue (TTM) | $595.03M |
| Gross Profit (TTM) | $265.16M |
| EBITDA | $37.33M |
| Operating Margin | -4.10% |
| Return on Equity | 1.53% |
| Return on Assets | -0.59% |
| Revenue/Share (TTM) | $12.99 |
| Book Value | $37.26 |
| Price-to-Book | 0.68 |
| Price-to-Sales (TTM) | 1.88 |
| EV/Revenue | 1.35 |
| EV/EBITDA | 21.56 |
| Quarterly Earnings Growth (YoY) | 8778.00% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $46.06M |
| Float | $40.65M |
| % Insiders | 0.92% |
| % Institutions | 118.89% |
Volatility is currently expanding